ARCHIVES

Lilly Suspends Phase III Trial Of Tasisulam in Melanoma

This article is from The Cancer Letter archive.

Vol. 34 No. 1 | January 28, 2011

Download PDF Visit The Full Archive

Related Articles

NCI Director’s Office Gets Makeover In Reorganization Plan.

December 8, 2006

NCAB Okays Effort To Relax $5 Million Limit On Center Core Grants In Cancer Act Renewal

November 19, 1976

NCAB Wants NCI To Avoid Setting Guidelines Regarding Health Policy

March 4, 1994

Richard Pestell, of Georgetown University, to direct Kimmel Cancer Center at Thomas Jefferson University.

November 11, 2005

Entire Construction Budget In 1983 Goes to Two Grants; Help May Be On The Way

February 25, 1983

Cancer Vaccine RFAs Approved In Concept By NCI Advisors

July 26, 1991